Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook



 

Genetic variants linked to start of Huntington's symptoms

03 August 2015

By Dr Victoria Burchell

Appeared in BioNews 813

A genome-wide study of over 4000 people with Huntington's disease has identified the location several new gene variants that influence the onset of disease symptoms.

Huntington's disease is caused by a single gene and is characterised by uncontrolled movements, cognitive decline and psychiatric symptoms. These symptoms usually develop in middle age, but the age of onset varies between individuals.

'By understanding the mechanisms by which nature influences the age of onset of this devastating condition, we have identified a target for potential treatments. If we can develop a way to interfere with these processes, then we could possibly delay or even prevent the onset of the disease,' said Professor Lesley Jones of Cardiff University, who led the UK arm of the multicentre study.

It has been known for more than 20 years that variations in the Huntington's disease gene itself influences the timing of symptoms, but this did not explain all of the variation. So the scientists analysed the entire genomes of over 4000 Huntington's disease patients from the United States and Europe to search for other genes responsible.

They identified two gene variants on chromosome 15 – one was associated with a 1.4-year delay in disease onset while the other accelerated disease onset by approximately six years. Another variant on chromosome 8 was also associated with an earlier disease onset.

'Figuring out the exact DNA sequence variations responsible and how they influence the disease process should provide us with a guide for developing drugs that we hope could have a much larger effect than the one to six years produced by the natural variations, possibly even preventing symptom onset altogether,' said Dr James Gusella, Director of Massachusetts General Hospital's Center for Human Genetic Research and corresponding author of the study, which was published in the journal Cell.

Professor Jones stressed that treatments based on this research may still be a decade or more away. 'Our findings may not be able to help those already affected by Huntington's disease, but this could prove to be a turning point in how we treat the disease in future generations,' she said.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

26 June 2017 - by Meghna Kataria 
Eliminating the faulty protein that causes Huntingdon's disease goes some way to reversing disease progression in mice, a study has found...
12 June 2017 - by Lea Goetz 
Scientists have identified the first promising biomarker for Huntington's disease (HD) that could be harnessed in a simple blood test to predict disease onset and progression...

13 July 2015 - by Dr Julia Hill 
Julia Hill reviews 'The Lion's Mouth Opens', a moving portrait of Huntington's Disease...
20 May 2013 - by Dr Mair Crouch 
Preimplanatation genetic diagnosis (PGD) is a technique that allows couples from families with history of certain inheritable diseases to try and reduce their risk of having a child affected by the condition....
25 June 2012 - by Holly Rogers 
A single dose of an 'antisense' drug has been shown to slow, or even partially reverse, Huntington's disease in animal studies, according to a study published in Neuron....
23 January 2012 - by Dr Zara Mahmoud 
Two independent studies have suggested new targets for treating neurodegenerative diseases...
04 May 2010 - by Dr Vivienne Raper 
Huntington's Disease affects families as much as individuals; affected parents have a 50 per chance of passing it to their children. This fact makes this book describing the effects of Huntington's on an entire family such a thought-provoking read. And it's funny, chatty and uplifting too...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation